1428523-24-3Relevant articles and documents
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES
-
Page/Page column 198; 199, (2016/10/31)
Site-specific antibody-drug conjugates are described, in particular conjugates comprising an antibody which binds PSMA, and which comprises an amino acid substitution of an interchain cysteine residue by an amino acid that is not cysteine and pyrrolobenzo
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES
-
Page/Page column 194-195, (2016/11/02)
Site-specific antibody-drug conjugates are described, in particular conjugates comprising pyrrolobenzodiazepines (PBDs) having a labile protecting group in the form of a linker. The site of conjugation, along with modification of the antiobody moiety, all
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES
-
Page/Page column 209-210, (2016/10/31)
Site-specific antibody-drug conjugates are described, in particular conjugates comprising pyrrolobenzodiazepines (PBDs) having a labile protecting group in the form of a linker. The site of conjugation, along with modification of the antiobody moiety, all